Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri.

Posted on January 16, 2013 by Maurice Preter MD

Biol Pharm Bull. 2006 Sep;29(9):1976-9. Cancer chemopreventive effects and cytotoxic activities of the triterpene acids from the resin of Boswellia carteri. Akihisa T, Tabata K, Banno N, Tokuda H, Nishimura R, Nakamura Y, Kimura Y, Yasukawa K, Suzuki T. Source … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, Psychiatry/Neurology | Tagged , , |

Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention Study in Ongoing Neurological Surveillance.

Posted on January 16, 2013 by Maurice Preter MD

Arch Neurol. 2012 Feb;69(2):183-90. doi: 10.1001/archneurol.2011.1426. Epub 2011 Oct 10. Association between immediate initiation of intramuscular interferon beta-1a at the time of a clinically isolated syndrome and long-term outcomes: a 10-year follow-up of the Controlled High-Risk Avonex Multiple Sclerosis Prevention … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Health, keto, Psychiatry/Neurology | Tagged , , |

Cancer risk in multiple sclerosis: findings from British Columbia, Canada.

Posted on January 16, 2013 by Maurice Preter MD

Good news but probably offset by use of immune-modulating/suppressive interventions (especially of cellular immunity) for MS. Do neurologists explain that to their patients? Another study to be done. Brain. 2012 Oct;135(Pt 10):2973-9. doi: 10.1093/brain/aws148. Epub 2012 Jun 21. Cancer risk … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto | Tagged , , , |

Modifiable factors influencing relapses and disability in multiple sclerosis.

Posted on January 16, 2013 by Maurice Preter MD

Mult Scler. 2010 Jul;16(7):773-85. doi: 10.1177/1352458510367721. Epub 2010 May 18. Modifiable factors influencing relapses and disability in multiple sclerosis. D’hooghe MB, Nagels G, Bissay V, De Keyser J. Source National Center For Multiple Sclerosis, Melsbroek, Belgium. marie.dhooghe@ms-centrum.be Abstract A growing … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, Health, keto, Psychiatry/Neurology | Tagged , , , , |

Fingolimod treatment for multiple sclerosis patients What do we do with varicella?

Posted on January 16, 2013 by Maurice Preter MD

Fingolimod treatment for multiple sclerosis patie… [Ann Neurol. 2011] – PubMed – NCBI. Ann Neurol. 2011 Oct;70(4):673-4; author reply 674. doi: 10.1002/ana.22605. Fingolimod treatment for multiple sclerosis patients What do we do with varicella? Winkelmann A, Loebermann M, Reisinger EC, … Continue reading →

Posted in Fifth Avenue Concierge Medicine, Forensic Neuropsychiatry, keto, new treatments, Psychiatry/Neurology | Tagged , , , , |